Effect of stem cell factor, interleukin-6, nitric oxide and transforming growth factor-β on the osteoclast differentiation induced by 1α,25- (OH)2D3 in primary murine bone marrow cultures

Pharmacology and Toxicology

Volumn 82, Issue 5, 1998, Pages 223-229

  Chae, Han Jung ^a   Park, Rae Kil ^b   Kang, Jang Sook ^a   Shin, Hyung Shik ^a   Kim, Sang Chul ^a   Chung, Hun Taeg ^b   Son, Dong Whan ^c   Ko, Kun I L ^c   Kim, Jae Baek ^c   Park, Young Chul ^d   Kim, Hyung Ryong ^a,c  

^a Institute Wonkwang Biomaterial Implant   (South Korea)

^b Department of Physiology School of Medicine   (South Korea)

^c Wonkwang University   (South Korea)

^d Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; CALCITRIOL; NITRIC OXIDE; NITROPRUSSIDE SODIUM; RECOMBINANT INTERLEUKIN 6; RECOMBINANT STEM CELL FACTOR; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; MOUSE; MULTINUCLEAR CELL; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL;

ANIMALIA; MURINAE;

EID: 0031810842     PISSN: 09019928     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0773.1998.tb01429.x     Document Type: Article

References (47)

1. Akatsu, T., N. Takahashi, K. Debari, I. Morita, S. Murota, N. Nagata, O. Takatani & T. Suda: Prostaglandins promote osteoclast-like cell formation by a mechanism involving cyclic adenosine 3′, 5′-monophosphate in mouse bone marrow cell cultures. J. Bone Miner. Res. 1989, 4, 29-35.
2. Baron, R., A. Vignery & M. Horowitz: Lymphocytes, macrophages and the regulation of bone remodeling. Bone Miner. Res. 1983, 2, 175-243.
3. Bertolini, D. R., G. E. Nedwin, D. Bringman, D. Smith & G. R. Mundy: Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors. Nature 1986, 319, 516-519.
4. Bonewald, L. F. & G. R. Mundy: Role of transforming growth factor-beta in bone remodelling. Clin. Orthop. Relat. Res. 1990, 250, 261-276.
5. Broxmeyer, H. E., G. Hamjoc, S. Cooper, D. Anderson, D. Cosnian, S. D. Lyman & D. E. Williams: Influence of murine mast cell growth factor c-kit ligand on colony formation by mouse marrow hematopoietic progenitor cells. Exp. Hematol. 1991, 19, 143-146.
6. Burr, D. B., R. B. Martin, M. B. Schaffler & E. L. Radin: Bone remodeling in response to in vivo fatigue microdamage. J. Biomech. 1985, 18, 189-200.
7. Chae H. J., R. K. Park, H. T. Chung, J. S. Kang, M. S. Kim, D. Y. Choi, B. G. Bang & H. R. Kim: Nitric oxide is a regulator of remodelling. J. Pharm. Pharmacol. 1997, 49, 897-902.
8. Chenu, C., J. Pfeilschifter, G. R. Mundy & G. D. Roodman: Transforming growth factor-β inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc. Natl. Acad. Sci. USA 1988, 85, 5683-5687.
9. Copeland, N. G., D. J. Gilbert, B. C. Cho, P. J. Donovan, N. A. Jenkins, D. Cosman, D. Anderson, S. D. Lyman & D. E. Williams: Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990, 63, 175-183.
10. Damoulis, P. D. & P. V. Hauschka: Nitric oxide acts in conjunction with proinflammatory cytokine to promote cell death in osteoblasts. J. Bone Miner. Res. 1997, 12, 412-422.
11. Demulder, A., S. V. Suggs, K. M. Zsebo, T. Scarcez & G. D. Rood-man: Effects of stem cell factor on osteoclast-like cell formation in long-term human marrow cultures. J. Bone Miner. Res. 1992, 11, 1337-1344.
12. Feyen, J. H. M., P. Elford, F. E. Dipadova & U. Trechsel.: Interleukin-6 is produced by bone and modulated by parathyroid hormone. J. Bone Miner. Res. 1989, 4, 633-638.
13. d mutant. Cell 1991, 64, 1025-1035.
14. Frame, B. & A. K. Nixon: Bone marrow mast cells in osteoporosis of aging. New Engl. J. Med. 1968, 279, 626-630.
15. Fukumoto, S., T. Matsumoto, S. Harada, J. Fujisaki, M. Kawano & E. Ogata: Pheochromocytoma with pyrexia and marked inflammatory signs: A paraneoplastic syndrome with possible relation to interleukin-6 production. J. Clin. Endocrinol. Metab. 1991, 73, 877-881.
16. Gowen, M., G. E. Nedwin & G. R. Mundy: Preferential inhibition of cytokine stimulated bone resorption by recombinant interferon gamma. J. Bone Miner. Res. 1986, 1, 469-473.
17. Hoyland, J. A., A. J. Freemont & P. T. Sharpe: Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J. Bone Miner. Res. 1994, 9, 75-80.
18. Huang, E., K. Nocha, D. R. Beier, T. Chu, J. Buck, H. W. Lahue, D. Wellner, P. Leder & P. P. Beamer: The hematopoietic growth factor VL is encoded by the steel locus and is the ligand of the c-kit receptor, the gene product of the W locus. Cell 1990, 63, 225-233.
19. Ishimi, Y., C. Miyaura, C. H. Jin, T. Akatsu, E. Abe, Y. Nakamura, A. Yamaguchi, S. Yoshika, T. Matsuda, T. Hirano, T. Kishimoto & T. Suda: IL-6 is produced by osteoblasts and induces bone resorption. J. Immunol. 1990, 145, 3297-3303.
20. Jilka, R. L., G. Hangoc, G. Girasole, G. Passer, D. C. Williams, J. S. Abrams, B. Boyce, H. Broxmeyer & S. C. Manolagas: Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 1992, 257, 88-91.
21. Kishimoto, T.: The biology of interleukin-6. Blood 1989, 74, 1-10.
22. Lowenstein, C. J. & S. H. Snyder: Nitric oxide, a novel biological messenger. Cell 1992, 70, 705-707.
23. Löwik, C. W. G. M., G. van der Pluijim, H. Bloys, K. Hoekman, O. L. M. Bijvoet, L. A. Aarden & S. E. Papapoulos: Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesis. Biochem. Biophys. Res. Commun. 1989, 162, 1546-1552.
24. Löwik, C. W. G. M., P. H. Nibbering, M. Van der Ruit & S. E. Papapoulos: Inducible production of nitric oxide in osteoblast-like cells and in fetal mouse bone expiants is associated with suppression of osteoclastic bone resorption. J. Clin. Invent. 1994, 93, 1465-1472.
25. MacIntyre, I., M. Zaidi, A. S. T. Towhidul, Alam, H. K. Datta, B. S. Moonga, P. S. Lidbury, M. Hecker & J. R. Vane: Osteoclast inhibition: An action of nitric oxide not mediated by cyclic GMP. Proc. Natl. Acad. Sci. USA 1991, 88, 2936-2940.
26. Marceli, C., A. J. Yates & G. R. Mundy: In vivo effects of human recombinant transforming growth factor-β on bone turnover in normal mice. J. Bone Miner. Res. 1991, 5, 1087-1096.
27. Matsui, Y., K. M. Isebo & B. L. M. Hegan: Embryonic expression of a hematopoietic growth factor encoded by the Sl locus and the ligand for c-kit. Nature 1990, 347, 667-669.
28. McNiece, I. K., K. E. Langley & K. M. Zsebo: Recombinant human stem cell factor synergizes with GM-CSF, G-CSF, IL-3 and EPO to stimulate human progenitor cells of the myeloid and erythroid lineages. Exp. Hemato. 1991, 19, 226-231.
29. Moncada, S., R. M. J. Palmer & E. A. Higgs: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev. 1991, 43, 109-142.
30. Mundy, G. R. & G. D. Roodman: Osteoclast ontogeny and function. Bone Miner. Res. 1987, 5, 209-279.
31. Nijweide, P. J., E. H. Burger & J. H. M. Feyen: Cells of bone: proliferation, differentiation, and hormonal regulation. Physiol. Rev. 1986, 66, 855-889.
32. Noda, M. & J. Camilliere: In vivo stimulation of bone formation by transforming growth factor-β. Endocrinology 1989, 124, 2991-2994.
33. Nussler, A. K., M. Disilvio, T. R. Billiar, R. A. Hoffman, D. A. Geller, R. Selby, J. Madrigas & R. L. Simmons: Stimulation of the nitric oxide synthase pathway in human hepatocytes by cytokines and endotoxin. J. Exp. Med. 1992, 176, 261-264.
34. Ohsaki, Y., T. Scarcez, R. Williams & G. Roodman: Interleukin-6 is a potential autocrine factor responsible for the intensive bone resorption by multinucleated giant cells in giant cell tumors of bone. J. Bone Miner. Res. 1991, 6, S265.
35. Oreffo, R. O. C., G. R. Mundy, S. M. Seyedin & L. F. Bonewald: Activation of the bone-derived latent TGF beta complex by isolated osteoclasts. Biochem. Biophys. Res. Commun. 1989, 58, 817-823.
36. Pfeilschifter, J., S. M. Seyedin & G. R. Mundy: Transforming growth factor β inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 1988, 82, 680-685.
37. Pfeilschifter, J., S. M. D'Souza & G. R. Mundy: Effects of transforming growth factor-β on osteoblastic osteosarcoma cells. Endocrinology 1987, 121, 212-218.
38. Ralston, S. H. & P S. Grabowski: Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins. Bone 1996, 19, 29-33.
39. Ralston, S. H., M. Helfrich, P. S. Grabowski & N. Benjamin: A role for nitric oxide in the regulation of cytokine-induced resorption. J. Bone Miner. Res. 1993, 8, 383 (abstract).
40. Roodman, G. D., N. Kurihara, Y. Ohsaki, A. Kukita, D. Hosking, A. Demulder, J. F. Smith & F. R. Singer: Interleukin-6: A potential autocrine paracrine factor in Paget's disease of hone. J. Clin. Invest. 1992, 89, 46-52.
41. Seyedin, S. M., T. C. Thomas, A. Y. Thompson, D. M. Rosen & K. A. Piez: Purification and characterization of two cartilage-inducing factors from bovine demineralized bone. Proc. Natl. Acad. Sci. USA 1985, 82, 2267-2271.
42. Seyedin, S. M., A. Y. Thompson, H. Bentz, D. M. Rosen, J. M. McPherson, A. Conti, N. R. Siegel, G. R. Galluppi & K. A. Piez: Cartilage-inducing factor-A : Apparent identity to transforming growth factor-β. J. Biol. Chem. 1986, 261, 5693-5695.
43. Tashjian, A. H., E. F. Voelkel, M. Lazzaro, F. R. Singer, A. B. Roberts, R. Derynck, M. E. Winkler & L. Levine: Alpha and beta transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. Proc. Natl. Acad. Sci. USA. 1985, 82, 4535-4538.
44. Thompson, D. D. & G. A. Rodan: Indomethacin inhibition of tenotomy-induced bone resorption in rats. J. Bone Miner. Res. 1988, 3, 409-414.
45. Wagge, A., C. Kaufmann, E. Terje & G. Husby: Interleukin-6 in synovial fluid from patients with arthritis. Clin. Immunol. Immunopathol. 1989, 50, 394-398.
46. Weinreb, M., G. A. Rodan & D. D. Thompson: Osteopenia in the immobilized rat hind limb is associated with increased bone resorption and decreased bone formation. Bone 1989, 10, 187-194.
47. Zsebo, K. M., D. E. Williams, E. N. Jeissler, V. C. Broudy, F. H. Martin, H. L. Atkins, R. Hsu, N. C. Birkett, K. H. Okino, D. C. Murdock, F. W. Jacobsen, F. E. Langley, K. A. Smith, T. Takeishi, B. M. Caltamach, S. J. Galli, & S. V. Suggs: Stem cell factor is encoded at the steel locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 1990, 63, 213-224.